Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration
Sign Up to like & getrecommendations! Published in 2022 at "Advanced Materials"
DOI: 10.1002/adma.202106723
Abstract: Current pharmacological interventions for Parkinson's disease (PD) remain unsatisfactory in clinical settings. Inflammasome‐mediated pyroptosis represents a potential therapeutic target for the alleviation of neurodegenerative diseases. The development of inflammasome‐mediated pyroptosis agonists or antagonists may transform… read more here.
Keywords: pyroptosis inhibitor; blue nanozyme; pyroptosis; nanozyme pyroptosis ... See more keywords